Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Multi-omics analysis unveils a four-gene prognostic signature in esophageal squamous carcinoma and the therapeutic potential of PKP1

Fig. 5

Prognostic effects of risk score in ESCC patients. (A) Significant differences in OS between high- and low-risk groups. (B) Differences in ESCC cluster composition between high- and low-risk patients. (C-D) OS differences between high- and low-risk ESCC patients across tumor stages (C) and grades (D). (E-F) OS differences between high- and low-risk ESCC patients across age groups (E) and genders (F). (G-H) The OS difference between high- and low-risk ESCC patients with different alcohol (G) and tobacco (H) use histories. (I) OS differences among ESCC patients with different tumor locations (J) OS difference among ESCC patients with different adjuvant therapy histories. Kaplan-Meier survival analysis with log-rank test and Chi-square test were used and p < 0.05 was considered significant

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us